Report cover image

United States Liquid Biopsy Growth Opportunities

Publisher Frost & Sullivan
Published Feb 22, 2022
Length 73 Pages
SKU # MC16995831

Description

United States Liquid Biopsy Growth Opportunities

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio.

Advances in next-generation sequencing-based companion diagnostics (CDx) and liquid biopsy (LBx) enable precision medicine approaches toward diseases such as cancer. Another aspect changing the diagnostics industry is linking automation to digital technologies to improve efficiency and productivity. This includes leveraging artificial intelligence to enhance workflow and accuracy.

Frost & Sullivan’s analysis shows that the top 5 companies in the US liquid biopsy market—Exact Sciences, Guardant Health, Roche/Foundation Medicine, Natera, and LabCorp—account for 77.5% of its revenue in 2020. We expect the market to reach $7.02 billion by 2025 at a 14% CAGR.

The report provides updates on the competitive landscape by analyzing market dynamics, participants, and investments. It also offers stakeholders insights through forecasts, analysis by therapy (oncology and non-oncology) and product type (kits and reagents, instruments and analysis platforms, testing and development services), and growth opportunities.

Table of Contents

73 Pages
    • Why is it Increasingly Difficult to Grow?
    • The Strategic Imperative 8TM
    • The Impact of the Top Three Strategic Imperatives on the Liquid Biopsy Market
    • Growth Opportunities Fuel the Growth Pipeline Engine TM
    • Scope of Analysis
    • Segmentation by Therapy
    • Segmentation by Product Type
    • Key Competitors by Product Type and Therapy
    • Terminologies
    • Major cfNA Analysis Methods are PCR- or NGS-based
    • Review of Liquid Biopsy Applications by Analytes in Cancer
    • cfNA Diagnostics Applications across the Cancer Care Continuum
    • Key Growth Metrics
    • Growth Drivers
    • Growth Restraints
    • Regulatory Landscape
    • Forecast Assumptions
    • Revenue Forecast
    • Revenue Forecast by Therapy
    • Revenue Forecast by Oncology Product/Service Type
    • Revenue Forecast by NIPT Product/Service Type
    • Revenue Forecast for Other Products/Services
    • Revenue Forecast Analysis
    • Revenue Forecast Analysis by Selected Products/Services
    • Revenue Forecast Analysis by Therapy
    • Competitive Environment
    • Revenue Share
    • Revenue Share-Oncology Therapy
    • Revenue Share-NIPT Therapy
    • Revenue Share Analysis
    • Key Growth Metrics
    • Revenue Forecast-Oncology Therapy
    • Revenue Forecast Analysis-Oncology Therapy
    • Key Growth Metrics
    • Revenue Forecast-Non-oncology Therapy
    • Revenue Forecast Analysis-Non-oncology Therapy
    • Competitive Ecosystem
    • Competitor Matrix
    • Key Company Profiles
    • Key Company Product Matrix
    • Funding Trends
    • Mergers & Acquisitions and Partnerships
    • Growth Opportunity 1-Use AI-ML on Liquid Biopsy Data to Identify Novel Biomarkers
    • Growth Opportunity 2-Expand Liquid Biopsy NGS as CDx through Co-development Partnerships
    • Growth Opportunity 3-cfDNA Methylation as a Pan-cancer Screening Biomarker
    • Growth Opportunity 4-Liquid Biopsy for Early Neurodegenerative Disease Detection
    • Growth Opportunity 5-Comprehensive Cancer Profiling to Improve Cancer Management for Hospitals and Laboratories
    • Your Next Steps
    • Why Frost, Why Now?

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us